Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially ...

GSK is pleased to announce that Nucala (mepolizumab) has received a positive reimbursement recommendation with conditions from Canada's Drug Agency (CDA-AMC). The agency recommends that Nucala be ...

A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%. An ...

Add Yahoo as a preferred source to see more of our stories on Google. Woman's World has affiliate partnerships. We receive compensation when you click on a link and make a purchase. Learn more! Sure, ...

FLORENCE, Italy — Exacerbations remain one of the major unresolved challenges in the management of chronic obstructive pulmonary disease (COPD), despite the introduction of new therapies. However, ...

Respiratory nurses in the North East are among those pioneering a radical new treatment for patients with COPD.

We live longer and longer, and as we age, a lot of us develop a series of health issues and chronic diseases, including chronic obstructive pulmonary disease (COPD), which is found in around 600 ...

We live longer and longer, and as we age, a lot of us develop a series of health issues and chronic diseases, including Chronic Obstructive Pulmonary Disease (COPD), which is found in around 600 ...

Add Yahoo as a preferred source to see more of our stories on Google. Jacksonville police seize 4.3 kilograms of fentanyl, enough for 215,000 lethal doses St. Vincent's Riverside is now offering a ...

A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials, ...

More than 16 million Americans have COPD, and millions more likely have it without knowing.

When you have chronic obstructive pulmonary disease (COPD), many factors go into what type of treatment youll receive, including the severity of your condition and your symptoms. But one variable is ...